Michael Lam
Phase 1 Student
Locations
- Medical Scientist Training Program
Contact Information
Education
Research Interests
Neurodegenerative diseases and cancer biology
Research Experience
National Institute of Health, June 2021-August 2021
Advisor: Dr. Claire le Pichon
Project: ATF3 Expression Upregulated in Regenerating Motor Neurons Following Specific Nerve Injury
California State University-Long Beach (RISE Fellow), Sep 2017-May 2021
Advisor: Dr. Jason Schwans
Project: Fmoc-Dipeptides as a Scaffold to Systematically Investigate Inhibitors of Butyrylcholinesterase, an Enzyme Implicated in Alzheimer's Disease
California State University-Long Beach, Dec 2020-May 2021
Advisor: Kashima Samuels
Project: Addressing Attrition Rates Among UHP Students: A Retrospective Alumni Study
Meeting Abstracts
Characterizing injury marker expression in motor neurons after sciatic nerve trauma in mouse; National Institute of Health Summer Internship Poster Day 2021, Aug 2021. [Zoom poster]
Fmoc-Dipeptides as a Scaffold to Systematically Investigate Inhibitors of Butyrylcholinesterase, an Enzyme Implicated in Alzheimer's Disease; CSULB Honors' Program Thesis Presentations 2021, May 2021. [Zoom Oral Presentation]
Fmoc-Dipeptides as a Scaffold to Systematically Investigate Inhibitors of Butyrylcholinesterase, an Enzyme Implicated in Alzheimer's Disease. Annual Biomedical Research Conference 2019, Nov 2019. [poster]
Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. CNSM Research Symposium at CSULB, Sep 2019. [Poster]
Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. SoCal Undergraduate Research Symposium at UCI; Sep 2019. [Poster]
Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. 2019 UROP Annual Research Symposium; May 2019. [Poster]
Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. Southern California Undergraduate Research, Mar 2019. [Poster]
Comparative Study Evaluating Fmoc-Lys(Mtt)-OH as a Selective Inhibitor of Butyrylcholinesterase. 2018 UROP Annual Research Symposium. May 2018.
General Interests
Reading, vlogging, gaming, and anime